INTRODUCTION {#s1}
============

Neuromyelitis optica (NMO; Devic\'s syndrome) is a demyelinating disease of the CNS that predominantly affects the spinal cord and optic nerves and shares many clinical and radiological features with multiple sclerosis (MS) \[[@OMV054C1]--[@OMV054C3]\]. NMO is considered as a disease entity after the discovery of a novel, pathogenic autoantibody (NMO-IgG or AQP4-Ab) in 2004 \[[@OMV054C4], [@OMV054C5]\].

NMO is a rare syndrome constituting \<1% of demyelinating disease \[[@OMV054C6], [@OMV054C7]\]. Clinical, MRI and spinal fluid features from several case series are illustrated in Table [1](#OMV054TB1){ref-type="table"} (<http://www.medscape.com/viewarticle/446182_4>). Prevalence estimates of prevalence of NMO in Japan is ∼14 per 1 000 000 \[[@OMV054C8]\], and of northwest England is ∼4 per 1 000 000 with a female-to-male ratio of 3 : 1. The Mayo Clinic proposed a revised set of criteria for diagnosis in 2006 (Table [2](#OMV054TB2){ref-type="table"}). Table 1:Clinical, MRI and spinal fluid features from several case seriesFeaturesNumber (proportion)Women/men87/36 (2.3 : 1)Average age at onset37Monophasic/polyphasic72/40 (1.8 : 1)Optic neuritis presentation50 (45%)Transverse myelitis presentation43 (38%)Combined optic neuritis/transverse myelitis presentation19 (17%)Autoimmune disease/antibodies28/104 (27%)Antecedent infection22/91 (24%)Normal brain (MRI)48/63 (76%)Abnormal spinal cord (MRI)55/58 (95%)Cerebrospinal fluid (CSF) pleocytosis63/85 (74%)\>50 cells/mm^3^27/84 (32%)CSF polymorphonucleocytes34/67 (51%)CSF oligoclonal bands23/77 (30%) Table 2:Mayo clinic criteria for NMOAbsolute criteria:Optic neuritisAcute myelitisSupportive criteria:Brain MRI not meeting criteria for MS at disease onsetSpinal cord MRI with contiguous *T*~2~-weighted signal abnormality extending over three or more vertebral segments, indicating a relatively large lesion in the spinal cordNMO-IgG-seropositive status (The NMO-IgG test checks the existence of antibodies against the aquaporin-4 antigen.)

Hashimoto\'s thyroiditis (chronic lymphocytic thyroiditis) is an autoimmune disease characterized by cell- and antibody-mediated immune processes against thyroid gland. Diagnosis requires observations of lymphocyte infiltration of thyroid and autoantibodies against thyroid peroxidase, thyroglobulin and thyroid hormone-stimulating receptor.

CASE REPORT {#s2}
===========

A 53-year-old woman was admitted in a local hospital on November 2013 with complaints of hiccups, vomiting and paraesthesias of left upper and lower limb from 5 days. Patient completely recovered in a period of 30 days. Only thyroid profile was abnormal, which was suggestive of hyperthyroidism for which she took no medication (Table [3](#OMV054TB3){ref-type="table"}). In July 2014, patient was admitted with complaints of weakness of bilateral lower limbs and left upper limb along with band-like sensation around the chest at the T4 level. Patient also complained of difficulty in seeing distant objects in right eye. An MRI scan of brain and spine revealed lesion in the spinal cord at the levels of C2--C5, enhancing signal was seen at the levels of C3--C5. Table 3:Thyroid profileInvestigationNovember 2013June 2014March 2015Normal rangeT3 (ng/dl)3001005075--200T4 (µg/dl)207.11.34.5--11.5TSH (µU/ml)23.210.42.3--4.0

Patient was given injection methylprednisolone 1 g intravenous for a period of 5 days and oral steroids for 4 weeks. However, the thyroid function tests were normal during that episode (Table [3](#OMV054TB3){ref-type="table"}). In February 2015, patient was admitted with fever, cough with expectoration, breathlessness, paraesthesias and diminished vision. She was diagnosed with left lower lobe pneumonia and treated. In March 2015, patient was brought to emergency room with complaints of bilateral lower limb weakness, bilateral upper limb weakness (distal \> proximal) and band-like sensation over the chest and hiccups. Mini-Mental Status Examination (MMSE) was 28/30 (Table [4](#OMV054TB4){ref-type="table"}). Vision was diminished to counting fingers in right eye. Other cranial nerves were normal. Table 4:MMSE of patientCategoryPossible pointsDescriptionOrientation to time5From broadest to most narrow. Orientation to time has been correlated with future decline.Orientation to place5From broadest to most narrow. This is sometimes narrowed down to streets and sometimes to floor.Registration3Repeating named promptsAttention and calculation5Serial sevens or spelling 'world' backwards. It has been suggested that serial sevens may be more appropriate in a population where English is not the first language.Recall3Registration recallLanguage2Naming a pencil and a watchRepetition1Speaking back a phraseComplex commands4Varies. Can involve drawing figure shown.

Hypertonia was noted in all limbs. Power was 3/5 bilaterally proximally and 2/5 distally in upper limbs. Lower limb power was 0/5 on admission but improved to 1/5 in 15 days. Upper limb reflexes were 2+ and knee and ankle reflexes were 3+. Babinski\'s reflex was present bilaterally. Loss of joint position and vibration sense till bilateral anterior superior iliac spine was revealed. Abdominal reflex was absent.

Antibodies to HSV1, HSV2, CMV, EBV, HBV, VZV, HCV and HIV in serum and cerebrospinal fluid, as well as sarcoidosis and tumor markers in serum, revealed no abnormality. Polymerase chain reaction in CSF for HSV1 and HSV2 was negative. Cerebrospinal fluid analysis demonstrated no oligoclonal bands. Immunological tests for ANA titer were 1 : 320; tests for anti-extractable nuclear antigen, anti-dsDNA, anti-cardiolipin, anti-β2GPI, lupus cells and cryoglobulins were negative. A thyroid profile was suggestive of hypothyroidism (Table [3](#OMV054TB3){ref-type="table"}). Laboratory studies confirmed the presence of antithyroid antibodies (Table [5](#OMV054TB5){ref-type="table"}). Table 5:Laboratory studiesInvestigationValuesNormal rangeHemoglobin (g/dl)1112--16Leukocyte count (cells/µl)70004500--10 000Platelet count (cells/µl)200 000150 000--400 000Aspartate aminotransferase (U/l)300--37Alanine aminotransferase (U/l)400--34Albumin (g/dl)3.93.5--5.2Globulin (g/dl)3.02.5--3.0Thyroid-stimulating hormone (µU/ml)10.42.3--4.0Free thyroxine (T4)0.5 ng/ml0.8--2.8 ng/dlAntithyroglobulin antibody (IU/ml)155\<10.0Antithyroid peroxidase (IU/ml)805\<10.0

MRI brain and spine revealed (i) hyperintensity in the cervical cord at lower half of C6 and upper half of C7 vertebral body (Figs [1](#OMV054F1){ref-type="fig"} and [2](#OMV054F2){ref-type="fig"}), (ii) hyperintensity in the thoracic cord at the level of T7, T8 and T9 (Figs [3](#OMV054F3){ref-type="fig"} and [4](#OMV054F4){ref-type="fig"}) and (iii) hyperintensity in the right optic nerve head (Fig. [5](#OMV054F5){ref-type="fig"}). Fine needle aspiration of thyroid confirmed lymphocytic infiltration (Figs [6](#OMV054F6){ref-type="fig"} and [7](#OMV054F7){ref-type="fig"}). Serology was positive for NMO-IgG. Patient was started on methylprednisolone 1 g/day for 5 days and azathioprine (2.5--3 mg/kg/daily). Patient showed marginal improvement in motor symptoms. Patient was started on thyroxine 25 µg and later increased to 75 µg. Figure 1:MRI cervical spine showing hyperintensity at the level of C6--C7. Figure 2:MRI cervical spine showing hyperintensity at the level of C6--C7. Figure 3:MRI spine showing hyperintensity at the level of T7, T8 and T9. Figure 4:MRI spine showing hyperintensity at the level of T7, T8 and T9. Figure 5:MRI brain showing hyperintensity in the right optic nerve head. Figure 6:FNAC showing lymphocytic infiltration of thyroid. Figure 7:FNAC showing lymphocytic infiltration of thyroid.

DISCUSSION {#s3}
==========

Devic\'s disease is a severe idiopathic immune-mediated inflammatory demyelinating disease that predominantly involves the spinal cord and optic nerves. The cardinal clinical features are longitudinally extensive transverse myelitis and optic neuritis. Several differences exist in the characteristics and outcomes of patients with the monophasic and relapsing forms (Table [6](#OMV054TB6){ref-type="table"}). Table 6:Characteristics of monophasic and relapsing NMOCharacteristicsMonophasicRelapsingFrequency (%)Less common (20)More common (80)Age of onset (year; median)2939Sex: ratio of females (%)5080--90History of autoimmune diseaseUncommon∼50%Optic neuritis/myelitis (%)4890Bilateral optic neuritis (%)178Simultaneous optic neuritis + myelitis (%)310Severity at nadirMore severeLess severeRespiratory failure 5 yearsRareApproximately one-thirdMortality rate (%)1032RecoveryGoodFair

The NMO-IgG autoantibody is highly specific (91%; 85--99%) and sensitive (73%; 58--76%), and has less common occurrence in MS. Its target antigen is AQP4, a richly distributed water-pump channel in the central spinal cord, hypothalamus, periventricular area and periaqueductal area. Spinal cord histopathology in NMO found loss of AQP4 in acute inflammatory lesions surrounding immunoglobulin and complement-deposited hyalinized small vessels.

Intravenous methylprednisolone 1 g daily for 5 days is the first-line therapy. Nakamura *et al*. \[[@OMV054C9]\] suggested a neuroprotective effect of high-dose steroids when given within first 2--3 days after onset of optic neuritis. Many severe NMO attacks respond inadequately to corticosteroid treatment. Plasma exchange and intravenous immunoglobulin were also tried for acute attacks.

Interferons and other MS therapies, such as natalizumab and fingolimod, may aggravate NMO as reported by some studies such as Min *et al.* \[[@OMV054C10]\] and Jacob *et al.* \[[@OMV054C11]\]. Current options are azathioprine, mycophenolate mofetil, rituximab, mitoxantrone, cyclophosphamide, methotrexate, intravenous immunoglobulin and prednisone. Rituximab (anti-CD20) has a rapid onset of action (full activity in 2 weeks) and less frequent dosing (two infusions every 6 months). In the absence of comparative controlled trials, no single drug is the best for every patient with NMO.

The association of NMO with autoimmune thyroiditis has been reported very rarely \[[@OMV054C12]\], even though autoimmune diseases occur frequently in patients with other autoimmune diseases. Steady progression of autoimmune thyroiditis from hyperthyroidism to hypothyroidism was noted over a period of 2 years. Early diagnosis and aggressive immunosuppressive treatment is of paramount importance in management of NMO. However, its role in autoimmune thyroiditis is not clearly known. IgG-NMO testing is very useful in diagnosis even if clinical and para-clinical autoimmune indices are available. Long-term immunosuppressive treatment is required to prevent relapses. Guarantor: S. Sreenivasa Rao.
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